The deal will add Surface Oncology’s clinical stage assets, SRF388 and SFR114, t...
The partnership will focus on selected targets from Cholesgen's early stage port...
Rosemont is targeting the single-use sachet market, shaping its decision to acqu...
The FDA extends the review period for GSK’s Sierra Oncology myelofibrosis drug m...
Medivir has already received patents for Fostrox in the EU, Japan, the US and a ...
For clinical trials operating across different counties, challenges with regulat...
Laurus Labs will establish a GMP facility at IIT Kanpur’s Techno Park facility.
In the latest edition of STAT's Health Tech newsletter: a chatbot that's cautiou...
The company hopes to work with other partners to bring Utidelone to market.
The deal will see expansion of research into genomic medicine and genetic diseases.
start-up.ai will be merged with Verix’s AI lab, and its co-founder and CEO Shaha...
Columvi is a CD20xCD3 T-cell engaging bispecific antibody designed to treat R/R ...
TT11X is an “off-the-shelf”, genetically modified cell therapy being trialed for...
The company plans to finish the round by September or October at the latest.
This comes amongst various wins for Keytruda in recent years.
The first patient has been dosed with Osivax’s broad-spectrum candidate in its P...
